Defence Therapeutics Inc.

BRIEF

published on 07/08/2024 at 08:05, 5 months 13 days ago

Defence Therapeutics ne reçoit aucune objection de Santé Canada pour un essai sur le mélanome

Essai De Phase I Thérapeutique De Défense Santé Canada AccuTOX Mélanome
PRESS RELEASE

published on 07/08/2024 at 08:00, 5 months 13 days ago

DEFENCE RECEIVES NO OBJECTION LETTER FROM HEALTH CANADA FOR PHASE I TRIAL OF ITS ACCUM-002 (ACCUTOX) AS AN ANTI-CANCER MOLECULE IN PATIENTS WITH MELANOMA
Defence Therapeutics Inc. receives Health Canada's No Objection Letter for Phase I trial of ACCUM-002 as anti-cancer drug in melanoma patients. The study aims to assess safety, tolerability, and efficacy of the drug

Health Canada Phase I Trial Defence Therapeutics Inc. Anti-cancer Molecule ACCUM-002
BRIEF

published on 07/01/2024 at 08:05, 5 months 20 days ago

AccuTOX de la Défense augmente l'efficacité des inhibiteurs de points de contrôle immunitaires

Oncologie Thérapeutique De Défense Produits Biopharmaceutiques Inhibiteurs De Points De Contrôle Immunitaires AccuTOX
BRIEF

published on 07/01/2024 at 08:05, 5 months 20 days ago

Defence's AccuTOX Boosts Immune Checkpoint Inhibitors Efficiency

Oncology Biopharmaceuticals Defence Therapeutics Immune Checkpoint Inhibitors AccuTOX
PRESS RELEASE

published on 07/01/2024 at 08:00, 5 months 20 days ago

DEFENCE’S ACCUTOX BOOSTS AND SYNERGIZES WITH IMMUNE CHECKPOINT INHIBITORS
Defence Therapeutics Inc. announces that AccuTOX synergizes with immune checkpoint inhibitors, transforming cold tumors into hot tumors for more efficient cancer treatment

Cancer Treatment Biopharmaceutical Defence Therapeutics Inc. Immune Checkpoint Inhibitors AccuTOX
BRIEF

published on 06/25/2024 at 08:05, 5 months 26 days ago

Defence's ARM-X Vaccine Shows Promising Results Against Ovarian Cancer in Pre-Clinical Trials

Defence Therapeutics Ovarian Cancer Immune-oncology ARM-X Pre-clinical Studies
BRIEF

published on 06/25/2024 at 08:05, 5 months 26 days ago

Le vaccin ARM-X de la Défense montre des résultats prometteurs contre le cancer de l'ovaire lors d'essais précliniques

Immuno-oncologie Thérapeutique De Défense Cancer Des Ovaires Etudes Précliniques ARM-X
PRESS RELEASE

published on 06/25/2024 at 08:00, 5 months 26 days ago

DEFENCE’S ARM-X ANTI-CANCER VACCINE INHIBITS GROWTH OF PRE-ESTABLISHED OVARIAN CANCER RESULTING IN COMPLETE RESPONSES IN TREATED ANIMALS
Defence Therapeutics Inc. announces successful inhibition of ovarian cancer growth with ARM-X anti-cancer vaccine and anti-PD-1 combination therapy in pre-established cancer models

Defence Therapeutics Inc. Ovarian Cancer Immune-oncology Anti-PD-1 ARM-X Vaccine
BRIEF

published on 06/17/2024 at 08:05, 6 months 4 days ago

Defence Therapeutics Inc. Highlights ACCUM Platform for Cancer Treatments

Biopharmaceutical Defence Therapeutics Cancer Treatments ACCUM Platform Dr. Moutih Rafei
BRIEF

published on 06/17/2024 at 08:05, 6 months 4 days ago

Defence Therapeutics Inc. présente la plateforme ACCUM pour les traitements contre le cancer

Biopharmaceutique Thérapeutique De Défense Traitements Contre Le Cancer Plateforme ACCUM Dr Moutih Rafei

Published on 12/21/2024 at 01:30, 1 day 4 hours ago

Quantum Biopharma Announces Closing of Second Tranche
Published on 12/21/2024 at 01:30, 1 day 4 hours ago

iMetal Resources Closes First Tranche of Previously Announced Non-Brokered Private Placement
Published on 12/21/2024 at 00:05, 1 day 6 hours ago

Chloeta Awarded GSA OASIS+ IDIQ Contract for Intelligence, Federal Civilian and Defense Support Services
Published on 12/21/2024 at 00:00, 1 day 6 hours ago

Amarc Announces Loan Extension
Published on 12/20/2024 at 23:30, 1 day 6 hours ago

Boron One Announces Extension to Early Warrant Exercise Incentive Program

View all ACCESSWIRE

Published on 12/21/2024 at 00:51, 1 day 5 hours ago

Acquisition of PSI Transcom GmbH by CHAPTERS platform Altamount Software GmbH
Published on 12/21/2024 at 00:45, 1 day 5 hours ago

EQS-Adhoc: PSI sells the Mobility business unit
Published on 12/20/2024 at 19:10, 1 day 10 hours ago

Funding Circle Plc: POS-Transaction in Own Shares
Published on 12/20/2024 at 18:56, 1 day 11 hours ago

CPI PROPERTY GROUP – Progress on Key Initiatives
Published on 12/20/2024 at 18:00, 1 day 12 hours ago

ARYZTA AG Announces New Board Technology Committee

View all EQS

Published on 12/21/2024 at 12:17, 17 hours 49 minutes ago

AXA annonce la signature d’un accord relatif à la vente d'AXA Investment Managers à BNP Paribas
Published on 12/21/2024 at 12:17, 17 hours 49 minutes ago

AXA announces the signing of a share purchase agreement with BNP Paribas relating to the sale of AXA IM
Published on 12/20/2024 at 18:00, 1 day 12 hours ago

Kapitaalverhoging door uitoefening van inschrijvingsrechten
Published on 12/20/2024 at 18:00, 1 day 12 hours ago

Capital increase through exercise of subscription rights
Published on 12/20/2024 at 17:55, 1 day 12 hours ago

Déclaration des transactions sur actions propres réalisées du 16/12/2024 au 20/12/2024

View all LES ECHOS COMFI WIRE

News